Dr. Reddy's Laboratories
Search results
6 days ago · Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs.
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]
A global biopharmaceutical company changing patients’ lives by finding new & affordable ways to treat diabetes, cancer & autoimmune diseases.
It’s a chance to work alongside some of the brightest minds in research, healthcare, pharmaceutical, biotechnology and business sectors. With a talented and diverse team, which works towards the common goal of making healthcare affordable and accessible globally, the possibilities are endless. MORE >>.
2 days ago · Biocon Share Price Today (28 Jun, 2024): Biocon Stock Price (₹ 351.10) Live NSE/BSE updates on The Economic Times. Check out why Biocon share price is up today. Get all details on Biocon Ltd.shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global...
Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals. Global scale manufacturing set up for biologics, biosimilars.
Biocon is addressing global medical needs through a portfolio of differentiated and high quality, life-saving biotherapeutics.
Biocon is a unique global biopharmaceutical company changing patients’ lives in over 120 countries. From drug discovery to drug delivery, we make life-saving medicines for the most feared diseases, to extend and significantly improve the quality of life.
We are committed to providing everyone, everywhere, affordable access to a speciality portfolio of medicines. We are steadfastly investing in developing novel therapies for diabetes, oncology and immunology. We are strengthening our global reach and economies of scale.
